Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Revisão |
| Язык: | английский |
| Опубликовано: |
2020
|
| Online-ссылка: | https://doi.org/10.1080/14737159.2020.1768849 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|